Pure Global

Xpert BCR-ABL Ultra - Taiwan Registration eb0231ae86ca1aba46fd819bc180fa18

Access comprehensive regulatory information for Xpert BCR-ABL Ultra in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number eb0231ae86ca1aba46fd819bc180fa18 and manufactured by CEPHEID. The authorized representative in Taiwan is PROGRESSIVE GROUP INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
eb0231ae86ca1aba46fd819bc180fa18
Registration Details
Taiwan FDA Registration: eb0231ae86ca1aba46fd819bc180fa18
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Xpert BCR-ABL Ultra
TW: ่‰พๆ–ฏๆŸ็‰น BCR-ABL ้ซ˜ๆ•ๆชขๆธฌ่ฉฆๅŠ‘็ต„
Risk Class 3
MD

Registration Details

eb0231ae86ca1aba46fd819bc180fa18

Ministry of Health Medical Device Import No. 031804

DHA05603180403

Company Information

United States

Product Details

This product is used with the GeneXpert Instrument System (DH Medical Device Transfusion No. 006789) to quantify BCR-ABL1 chromosomal translocation MRNA transcripts (type e/3a2/b2a2 or e14a2/b3a2) and ABL1 endogenous control MRNA transcripts for the detection of peripheral blood samples from patients with previously diagnosed chronic myeloid leukemia (CML). This product does not report specific types of BCR-ABL1 MRNA transcripts. This product is used to assist in monitoring BCR-ABL1 MRNA transcript content in peripheral blood samples of patients diagnosed with CML.

B Hematology and pathology devices

B4020 Analyze specific reagents

Imported from abroad

Dates and Status

Nov 27, 2018

Nov 27, 2023